Genetic Signatures Limited (ASX:GSS)

Genetic Signatures Revenue

In the fiscal year ending June 30, 2025, Genetic Signatures had annual revenue of 19.75M AUD with 43.47% growth. Genetic Signatures had revenue of 11.25M in the half year ending June 30, 2025, with 1.31% growth.

• Revenue: 19.75M
• Revenue Growth: +43.47%
• P/S Ratio: 1.67
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 32.94M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	19.75M	5.99M	43.47%
Jun 30, 2024	13.77M	-7.75M	-36.00%
Jun 30, 2023	21.51M	-13.98M	-39.39%
Jun 30, 2022	35.50M	7.11M	25.06%
Jun 30, 2021	28.38M	14.57M	105.43%